Results for neohesperidin

Antioxidant and pancreatic lipase inhibitory effects of flavonoids from different citrus peel extracts.

Article Published Date : Apr 10, 2020
Study Type : In Vitro Study
Additional Links
Substances : Citrus naringin : CK(465) : AC(260), Citrus Peel : CK(159) : AC(62), Hesperidin : CK(1002) : AC(381), neohesperidin
Diseases : Metabolic Syndrome X : CK(3159) : AC(560), Obesity : CK(11621) : AC(2822), Oxidative Stress : CK(16582) : AC(6561)
Pharmacological Actions : Antioxidants : CK(37547) : AC(15797), Enzyme Inhibitors: Pancreatic Lipase : CK(57) : AC(27)

Citrus flavonoids as promising phytochemicals targeting diabetes and related complications.

Article Published Date : Sep 22, 2020
Study Type : Review
Additional Links
Substances : Citrus naringin : CK(465) : AC(260), Diosgenin : CK(250) : AC(149), Flavonoids : CK(5539) : AC(2655), Fruit: All : CK(9498) : AC(2261), Hesperidin : CK(1002) : AC(381), Naringenin : CK(751) : AC(414), neohesperidin, Nobiletin : CK(411) : AC(249), Quercetin : CK(1925) : AC(877), Rutin : CK(468) : AC(225), Tangeretin : CK(206) : AC(114), Xanthohumol : CK(301) : AC(201)
Diseases : Diabetic Complications : CK(4953) : AC(1712)
Pharmacological Actions : Antioxidants : CK(37547) : AC(15797), Hepatoprotective : CK(9833) : AC(4180), Hypoglycemic Agents : CK(9865) : AC(2205), Hypolipidemic : CK(9809) : AC(2189), Renoprotective : CK(4959) : AC(2157)

Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells.

Article Published Date : Apr 13, 2018
Study Type : In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Endometrial Cancer : CK(556) : AC(138)
Pharmacological Actions : Apoptotic : CK(10549) : AC(8155)

Mechanistic and metabolic exploration of neohesperidin against lung cancer cell lines.

Article Published Date : May 31, 2025
Study Type : In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Lung Cancer : CK(3258) : AC(1551)
Pharmacological Actions : Antineoplastic Agents : CK(2527) : AC(1699), Apoptotic : CK(10549) : AC(8155)

Neohesperidin alleviates the inhibitory effect of bisphenol A on the myogenic differentiation of umbilical cord mesenchymal stem cells.

Article Published Date : Sep 14, 2024
Study Type : In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Bisphenol Toxicity : CK(4442) : AC(1344)
Problem Substances : Bisphenol A : CK(4596) : AC(1338)

Neohesperidin attenuates DSS-induced ulcerative colitis by inhibiting inflammation.

Article Published Date : Sep 17, 2024
Study Type : In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Inflammation : CK(17331) : AC(5987), Ulcerative Colitis : CK(1615) : AC(535)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43792) : AC(17574), Gastroprotective : CK(1819) : AC(764), NF-kappaB Inhibitor : CK(6633) : AC(3853)

Neohesperidin exerts antidepressant-like effect via the mechanistic target of rapamycin complex 1 in the medial prefrontal cortex in male mice.

Article Published Date : Sep 30, 2024
Study Type : Animal Study
Additional Links
Substances : neohesperidin
Diseases : Depression : CK(10250) : AC(1908)
Pharmacological Actions : Antidepressive Agents : CK(8557) : AC(1605)

Neohesperidin exerts lipid-regulating effects in vitro and in vivo.

Article Published Date : Dec 31, 2016
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Dyslipidemias : CK(1793) : AC(352)
Pharmacological Actions : Hypolipidemic : CK(9809) : AC(2189)

Neohesperidin improves depressive-like behavior.

Article Published Date : Jan 02, 2025
Study Type : Animal Study
Additional Links
Substances : neohesperidin
Diseases : Depression : CK(10250) : AC(1908)
Pharmacological Actions : Antidepressive Agents : CK(8557) : AC(1605)

Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.

Article Published Date : Jun 08, 2020
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Cardiac Hypertrophy : CK(258) : AC(142)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43792) : AC(17574), Antioxidants : CK(37549) : AC(15798), Cardioprotective : CK(10082) : AC(3193)

Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice.

Article Published Date : Nov 30, 2019
Study Type : Animal Study
Additional Links
Substances : neohesperidin
Diseases : Pulmonary Fibrosis: Bleomycin-Induced : CK(189) : AC(99)
Pharmacological Actions : Anti-Fibrotic : CK(2568) : AC(1220), Chemoprotective Agents : CK(4601) : AC(1765), Transforming growth factor beta (TGF-β) inhibitor : CK(668) : AC(337)

Neohesperidin mitigates high-fat-diet-induced colitis.

Article Published Date : Jan 09, 2025
Study Type : Animal Study
Additional Links
Substances : neohesperidin
Diseases : Colitis : CK(1716) : AC(820)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43792) : AC(17574), Gastrointestinal Agents : CK(8392) : AC(2565)

Neohesperidin prevents Aβ25-35-induced apoptosis in primary cultured hippocampal neurons.

Article Published Date : Jun 29, 2018
Study Type : In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Alzheimer's Disease : CK(5693) : AC(2394)
Pharmacological Actions : Neuroprotective Agents : CK(21800) : AC(8687)

Neohesperidin prevents colorectal tumorigenesis by altering the gut microbiota.

Article Published Date : Jan 09, 2019
Study Type : Transgenic Animal Study
Additional Links
Substances : neohesperidin
Diseases : Colorectal Cancer : CK(5145) : AC(2445)
Pharmacological Actions : Chemopreventive : CK(6693) : AC(2224), Gastrointestinal Agents : CK(8392) : AC(2565)

Neohesperidin protects against colitis-associated colorectal cancer.

Article Published Date : Jan 31, 2025
Study Type : Animal Study
Additional Links
Substances : neohesperidin
Diseases : Colitis : CK(1716) : AC(820), Colorectal Cancer : CK(5145) : AC(2445)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43779) : AC(17571), Apoptotic : CK(10549) : AC(8155), Chemopreventive : CK(6693) : AC(2224), Cyclooxygenase 2 Inhibitors : CK(2414) : AC(1417), Interleukin-1 beta downregulation : CK(6792) : AC(3289), Interleukin-6 Downregulation : CK(10280) : AC(4002), NF-kappaB Inhibitor : CK(6633) : AC(3853), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(12838) : AC(5293)

Neohesperidin suppresses IgE-mediated anaphylactic reactions.

Article Published Date : Jul 31, 2019
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Allergies : CK(2061) : AC(425), Anaphylactic Reaction : CK(18) : AC(8), IgE-Mediated Hypersensitivity : CK(86) : AC(26)
Pharmacological Actions : Immunomodulatory : CK(7017) : AC(2542)

The anti-aging potential of neohesperidin and its synergistic effects with other citrus flavonoids.

Article Published Date : Nov 12, 2019
Study Type : In Vitro Study
Additional Links
Substances : Flavonoids : CK(5539) : AC(2655), neohesperidin
Diseases : Aging : CK(6577) : AC(1619), Oxidative Stress : CK(16582) : AC(6561)
Pharmacological Actions : Antioxidants : CK(37549) : AC(15798)
Additional Keywords : Natural Substance Synergy : CK(1467) : AC(706)

The results suggest neohesperidin possesses therapeutic potential as a natural anti-catabolic treatment in osteoporosis.

Article Published Date : Jan 04, 2017
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Osteoporosis : CK(2942) : AC(823)
Pharmacological Actions : Anti-Apoptotic : CK(6306) : AC(3575), NF-kappaB Inhibitor : CK(6633) : AC(3853)
Additional Keywords : Ovariectomy-Induced Changes : CK(448) : AC(197)

Therapeutic effect of neohesperidin on TNF-α-stimulated human rheumatoid arthritis fibroblast-like synoviocytes.

Article Published Date : Sep 30, 2021
Study Type : In Vitro Study
Additional Links
Substances : neohesperidin
Diseases : Rheumatoid Arthritis : CK(2524) : AC(614)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43792) : AC(17574), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(12840) : AC(5294)

Therapeutic effects of citrus flavonoids neohesperidin, hesperidin and its aglycone, hesperetin on bone health.

Article Published Date : Jan 22, 2022
Study Type : Review
Additional Links
Substances : Flavonoids : CK(5539) : AC(2655), Hesperidin : CK(1002) : AC(381), neohesperidin
Diseases : Osteoarthritis : CK(2375) : AC(691), Osteoporosis : CK(2942) : AC(823), Periodontitis : CK(1415) : AC(337)
Pharmacological Actions : Anti-Inflammatory Agents : CK(43792) : AC(17574)

This study identified three lead compounds hesperidin, narirutin, and neohesperidin suitable for multitarget SARS-CoV-2 inhibition.

Article Published Date : Oct 27, 2022
Study Type : In Vitro Study
Additional Links
Substances : Flavonoids : CK(5539) : AC(2655), Hesperidin : CK(1002) : AC(381), neohesperidin
Diseases : Coronavirus Infection : CK(3253) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3311) : AC(1800)
Additional Keywords : SARS-CoV-2 Spike Protein

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2026 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.